Merck Vaccine Trial Delayed
The latest example of this trend is Merck KGaA’s impending all-cash acquisition of SpringWorks Therapeutics, valued around ...
Merck and a plaintiff have paused a trial over alleged injuries from the HPV vaccine Gardasil, with ties to HHS Secretary ...
Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the ...
Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare ...
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
The suit alleges defendants issued false statements concerning Merck business and prospects, resulting in its stock trading at inflated prices.
Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.
The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at least the middle of the year.
Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback